This physiological comparison chart displays breath-by-breath recordings of minute ventilation (VșE, L/min) and pulse oxygen saturation (SpO2, %) during a hypoxia exercise test across four phases: Resting Normoxia (RN), Resting Hypoxia (RH), Exercise Hypoxia (EH), and Exercise Normoxia (EN). The upper panel represents a subject with a high hypoxic ventilatory response (HVRe), while the lower panel shows a subject with a low HVRe. Both subjects exhibit a sharp decline in SpO2 during RH and EH, which recovers in the EN phase. The key educational focus is the respiratory stability difference during the EH phase: the high HVRe subject maintains a relatively stable, increasing VșE trend, whereas the low HVRe subject demonstrates pronounced periodic breathing, characterized by high-amplitude oscillations in minute ventilation and corresponding fluctuations in SpO2. These data illustrate the role of peripheral chemosensitivity in maintaining ventilatory stability under hypoxic stress and exercise conditions, relevant for studies in exercise physiology and high-altitude medicine.

A set of four line graphs (A-D) comparing respiratory physiological parameters between standard short interval exercise (SIESTD, solid line) and exercise with acute respiratory distress syndrome ventilation simulation (SIEARDS, dashed line) over a 27-minute duration. (A) Fraction of inspired carbon dioxide (FiCO2 %): SIEARDS displays markedly elevated, cyclical peaks exceeding 0.6% early on, while SIESTD remains stable below 0.1%. (B) Fraction of inspired oxygen (FiO2 %): SIEARDS shows significant dips reaching 19.9% early in the session, consistently tracking lower than the stable baseline of SIESTD. (C) End-tidal partial pressure of CO2 (PETCO2 mmHg): Both protocols show an initial rise followed by a gradual decline, with SIEARDS maintaining consistently higher partial pressure values throughout the exercise bouts. (D) Ventilation (VE L·min⁻¹): Both protocols exhibit cyclical peaks corresponding to exercise intervals, with SIEARDS demonstrating higher peak ventilation and higher baseline values during recovery periods. This chart illustrates the impact of restricted ventilation on gas exchange dynamics and compensatory ventilatory responses during high-intensity interval training.

This composite educational graphic details the physiological adjustments of the pulmonary and cardiovascular systems during prolonged exercise-induced dehydration and hyperthermia. On the left, a pathophysiology diagram centers on an anatomical illustration of the heart and lungs, surrounded by metabolic and respiratory equations. Red upward arrows indicate increases in ventilation (Vȩ), breathing frequency (fb), core temperature (Tc), and plasma catecholamines ([NA], [A]), signifying stimulatory effects (+) on central respiratory drive. Conversely, blue downward arrows indicate reductions in body fluids, arterial CO2 (PaCO2), and cardiac output (Q̇), with a (0) symbol noting factors that do not directly stimulate ventilation. The diagram illustrates how alveolar hyperventilation compensates for reduced systemic circulation to maintain oxygen uptake (VȩO2) and increase CO2 excretion (VȩCO2). On the right, a clinical photograph shows an endurance-trained participant in a laboratory setting, equipped with a metabolic mask, thoracic heart rate monitors, and peripheral arterial/venous catheters, demonstrating the experimental setup used to measure these cardiorespiratory variables during active exercise.

This diagnostic comparison chart displays six scatter plots illustrating respiratory gas exchange parameters from an incremental exercise test used for cardiopulmonary exercise testing (CPET). All plots use oxygen uptake (VO2 in ml/min) on the x-axis, ranging from 500 to 3000 ml/min. The vertical lines denote the first ventilatory threshold (VT1, dashed line) and the second ventilatory threshold (VT2, solid line). The y-axes measure: carbon dioxide output (VCO2), ventilation (VE), end-tidal CO2 pressure (PETCO2), respiratory exchange ratio (RER), the ventilatory equivalent for CO2 (VE/VCO2), and excess carbon dioxide output. Key physiological transitions are visible: VT1 typically corresponds to the point where VE/VO2 and PETCO2 begin to increase, while VT2 (the respiratory compensation point) is marked by a rapid, non-linear increase in VE, RER exceeding 1.0, and a secondary sharp rise in excess CO2 output. This chart is a standard tool in sports medicine and clinical physiology for assessing aerobic capacity and determining metabolic transition zones.

A clinical photograph of an adult male patient demonstrating extraocular muscle restriction during a diagnostic gaze test. The patient is attempting a superior-lateral (upper left) gaze. While the left eye successfully abducts and elevates, the right eye exhibits a failure to elevate during adduction, a clinical sign often associated with Brown syndrome or mechanical entrapment. A white arrow points to the right eye's medial canthus area, highlighting the restricted elevation. Visible periorbital ecchymosis (bruising) and swelling are present infraorbitally bilaterally, consistent with trauma or recent maxillofacial surgery. A faint horizontal surgical scar is visible on the left side of the face. This visual represents an orthoptic assessment of a patient with a nasoorbitoethmoidal (NOE) fracture, specifically illustrating preoperative diplopia and ocular motility deficits secondary to facial trauma. The image is intended for educational use in ophthalmology and trauma surgery to demonstrate mechanical restriction of the inferior oblique or superior oblique tendon complex.

Clinical photograph showing a preoperative orthoptic assessment of a 15-year-old male. The composite image displays a 3x3 grid (with seven active frames) documenting the nine cardinal positions of gaze. The patient is wearing a surgical cap and mask, with a 'Right Eye' label on the forehead for orientation. The assessment demonstrates a limitation of elevation in the right eye, most prominent when the eye is in an adducted position (looking toward the nose and up), characteristic of Brown syndrome. Specifically, in the top-left frame (leversion and elevation), the right eye shows a failure to elevate compared to the left eye, resulting in a vertical misalignment (hypotropia). The central frame shows orthotropia in the primary position. This visual documentation supports the diagnosis of traumatic Brown syndrome involving the superior oblique tendon, illustrating the classic mechanical restriction of the inferior oblique muscle's action during adduction.

A series of nine intraoperative clinical photographs illustrating a modified Harada-Ito procedure with an adjustable suture technique for the treatment of superior oblique muscle palsy. The images depict a surgical field of the human eye, showing the temporal and superior aspects of the sclera following conjunctival peritomy. Key anatomical structures visible include the sclera, conjunctiva, eyelashes, and the superior oblique tendon. The sequence demonstrates the identification and isolation of the anterior fibers of the superior oblique tendon using muscle hooks. Surgical instrumentation, including forceps, Westcott scissors, and various retractors, are used to manipulate the extraocular tissue. Non-absorbable sutures are shown being placed through the anterior portion of the superior oblique tendon and anchored more anteriorly and laterally on the sclera to achieve torsion correction. The final frames highlight the adjustable suture loop, allowing for postoperative alignment modification. This surgical montage is an educational resource for ophthalmic surgeons and residents, demonstrating the technical steps for correcting excyclotorsion through the selective advancement of the superior oblique tendon fibers.

A clinical photograph focusing on the periorbital region and eyes of a patient, demonstrating clinical improvement after 4 weeks of oral steroid therapy (1 mg/kg) for idiopathic acquired superior oblique (SO) palsy. The image shows the eyes in primary gaze with relatively symmetrical alignment. The irises are dark brown, and the sclera appears clear and non-icteric. There is a slight residual hyperdeviation of the left eye compared to the right, consistent with resolving hypertropia. The eyelids and surrounding skin are free of inflammatory signs, redness, or swelling. A small blue marking is visible on the patient's right eyebrow, likely a clinical marker for follow-up or examination. The visual illustrates the therapeutic response in a case of steroid-responsive cranial nerve palsy, where clinical features such as diplopia and ocular misalignment are being monitored during treatment tapering.

This anatomical and functional diagram illustrates the somatotopic organization of the human cerebellum across its four primary lobes: the Anterior Lobe, Superior Posterior Lobe, Inferior Posterior Lobe, and Flocculonodular Lobe. Key anatomical landmarks identified include the Primary Fissure (separating the anterior and posterior lobes), the Horizontal Fissure, and the Prepyramidal Fissure. The diagram features stylized homunculi representing multiple body maps within the cerebellar cortex. An inverted orange homunculus is shown in the Anterior Lobe, representing the primary sensorimotor map. In the Superior Posterior Lobe, secondary representations are depicted in blue. The Inferior Posterior Lobe contains a third upright representation shown in yellow. Specialized finger representations are localized within Lobule VI (indicated by pink shading). This illustration highlights the discrete spatial arrangement of body part representations—somatotopy—across different cerebellar lobules, which is essential for understanding the organ's role in motor planning, sequence detection, and cognitive processes like arithmetic and language. The vertical arrangement demonstrates the topographical relationship between the anatomical fissures and the functional sensory/motor areas.

This anatomical diagram presents a flattened or unfolded view of the human cerebellar cortex, illustrating the topographical arrangement of its lobes, fissures, and lobules. The map is divided into three primary regions: the Anterior Lobe (blue), the Posterior Lobe (beige), and the Flocculonodular Lobe (pink/purple). The central vertical axis represents the vermis (lobules I-X), flanked by the cerebellar hemispheres (labeled with H prefixes). Key landmarks include the primary fissure, which separates the anterior lobe (lobules I-V) from the posterior lobe (lobule VI and below), and the posterolateral fissure, which demarcates the flocculonodular lobe (lobule X). Notable lobules identified include the lingula, central lobule, culmen, simplex, crus I and II of the ansiform lobule, paramedian, biventer, tonsil, and uvula. Major anatomical fissures such as the precentral, preculminate, horizontal, ansoparamedian, and secondary fissures are precisely mapped to show the structural boundaries essential for neuroanatomical study and functional localization of motor and cognitive centers within the cerebellum.

Anatomical diagram representing a Larsell flatmap of the human cerebellum, color-coded to highlight four specific regions of interest (ROIs) for clinical study. The flatmap unfolds the cerebellar cortex into a two-dimensional view to illustrate the relationship between lobules and fissures. The yellow-shaded area identifies hemispheric lobules IV-VI in the anterior and superior posterior lobes, bordered by the preculminate and superior posterior fissures. The light blue region represents Crus I, delineated by the superior posterior and horizontal fissures. Below this, the green-shaded area indicates Crus II, bounded by the horizontal and ansoparamedian fissures. At the inferior-most pole, the orange region highlights Lobule X (flocculonodular lobe), separated by the posterolateral fissure. The central vermis is labeled with Roman numerals I-X, showing the midline organization. This visual aid is primarily used in neuroanatomical research and clinical imaging studies to define boundaries for stereological assays, particularly in investigations related to Purkinje cell density and neurodevelopmental disorders like autism.

Anatomical diagrams illustrating normal human cerebellar neurocircuitry and cortical microarchitecture. The left panel shows a macro-level view of the pathways between the cerebral cortex, brainstem (pons and inferior olivary nucleus), and cerebellum. It identifies the Superior Cerebellar Peduncle (SCP) and the Deep Cerebellar Nuclei (DCN). The right panel features detailed sagittal and transverse sections of the cerebellar cortex, organized into the molecular layer (ML), Purkinje cell layer (PCL), and granular layer (GL) above the white matter. Key cell types depicted include Purkinje cells (PC) with elaborate dendritic arbors, granule cells (Gr) forming parallel fibers (PF), stellate cells (SC), basket cells (BC), Golgi cells (Go), Lugaro cells (Lg), and unipolar brush cells (UB). The diagram highlights the two primary excitatory inputs: Climbing Fibers (CF) from the inferior olive directly innervating Purkinje cells, and Mossy Fibers (MF) from the pons/spinal nuclei synapsing in cerebellar glomeruli. The inhibitory output is provided by Purkinje cell axons projecting to the DCN, completing the regulatory loops relevant to motor control and cognitive function.

This pathophysiology diagram illustrates the cerebello-thalamo-cortical circuit and the mechanism of cerebellar brain inhibition (CBI) within a sagittal view of the human brain. The schematic highlights the functional connectivity between the Purkinje cells (PC) of the cerebellar cortex, the deep cerebellar nuclei (DCN), the thalamus (specifically the ventrolateral nucleus), and the motor cortex (MC). An external stimulus, representing transcranial magnetic stimulation (TMS), is depicted as a lightning bolt triggering an excitatory (+) effect on the Purkinje cells. This activation leads to an inhibitory (-) connection from the PC to the DCN. Subsequent excitatory (+) pathways are shown ascending from the DCN to the thalamus, and from the thalamus to the motor cortex. The diagram demonstrates how cerebellar activation can modulate motor cortex excitability through this multi-synaptic pathway. Key labels include MC (Motor Cortex), Thalamus, DCN (Deep Cerebellar Nuclei), and PC (Purkinje Cells), with red arrows indicating the flow of neural signals and +/- signs denoting the nature of the synaptic influence.

This figure presents a series of sagittal fluorescence microscopy images illustrating the expression of ELOVL4 in the developing cerebellum across four stages: embryonic day 18 (E18), postnatal day 10 (P10), P20, and P60. (A) At E18, ELOVL4 labeling is prominent in the nascent external granule cell layer (egl) and inner granule cell layer (igl) of the developing cerebellum (CB). (B) By P10, intense labeling persists in the egl and igl, with additional expression in cells traversing the molecular cell layer (mcl) and within the deep cerebellar nuclei, such as the interpositus nucleus (IP). (C) At P20, reflecting mature cerebellar layering, labeling is most intense in the granule cell layer (gcl), with moderate labeling in the Purkinje cell layer (pcl) and molecular layer. (D) The P60 stage shows a distribution pattern similar to P20, with continued high-intensity expression in the gcl and deep nuclei, including the fastigial nucleus (FN). These images demonstrate the developmental regulation of ELOVL4, a protein involved in the synthesis of very-long-chain fatty acids, primarily localized within neuronal cell bodies and specific cerebellar cortical layers.

**Imaging Modality:** Medical History Graphic/Collage. **Subject Matter:** Commemorative philatelic and numismatic items honoring Karl Landsteiner (1868–1943). **Key Features:** - **Central Elements:** A curved Austrian 1000-schilling banknote (Schilling note) featuring a portrait of Karl Landsteiner. - **Secondary Elements:** Two commemorative postage stamps superimposed on the banknote. One stamp is blue, issued by the Republic of Austria (*Republik Österreich*), and the other is green, issued by the German Democratic Republic (*DDR*). - **Textual Markers:** The banknote and stamps contain the name "Karl Landsteiner," his birth and death dates (1868–1943), and references to his Nobel Prize in Physiology or Medicine (1930). **Medical Historical Context:** Landsteiner is the pathologist and immunologist credited with the discovery of the major human ABO blood group system and the co-discovery of the Rh factor. These findings are foundational to the fields of hematology, transfusion medicine, and serology. **Clinical Significance:** This image documents the historical recognition of the development of blood typing and cross-matching, which enabled safe blood transfusions and advanced the understanding of immunohematology.

Summary : This flowchart outlines the recommended antenatal blood group and antibody screening process for pregnant women, adapted from the RCOG Greentop guideline 65 (2014). It details the steps for initial screening, follow-up testing, and management based on the presence or absence of clinically significant antibodies. flowchart: # Nodes : • At booking (rectangle): All pregnant women; ABO + D* typing; Antibody screen. • Clinically significant** antibody screen positive (rectangle) • No clinically significant** antibodies (rectangle) • Anti-D, -c or -K antibodies*** (rectangle): Offer paternal/fetal genotyping for corresponding antigen(s); Test monthly until 28 weeks’ gestation; See figure 2. • All other clinically significant** antibodies (rectangle): Offer paternal/fetal genotyping for corresponding antigen(s). • From 28 weeks’ gestation (rectangle): Test every 2 weeks until delivery; See figure 2. • Cord blood for: DAT, Hb, bilirubin (rectangle) • Repeat antibody screen at 28 weeks’ gestation (rectangle) • Repeat testing at 28 weeks’ gestation (rectangle) • No antibodies (rectangle) • No further action (rectangle) • Clinically significant antibodies (rectangle) # Connectors : • At booking splits into two branches: "Clinically significant** antibody screen positive" and "No clinically significant** antibodies". • "Clinically significant** antibody screen positive" splits into two branches: "Anti-D, -c or -K antibodies***" and "All other clinically significant** antibodies". • "Anti-D, -c or -K antibodies***" leads to "From 28 weeks’ gestation", which leads to "Cord blood for: DAT, Hb, bilirubin". • "All other clinically significant** antibodies" leads to "Repeat antibody screen at 28 weeks’ gestation". • "No clinically significant** antibodies" leads to "Repeat testing at 28 weeks’ gestation", which splits into "No antibodies" (leading to "No further action") and "Clinically significant antibodies". # Layout : • The flowchart is arranged in a top-down manner, starting with initial booking at the top, branching into two main pathways based on antibody screen results, and further subdividing based on antibody type and follow-up actions. • The left branch details management for clinically significant antibodies, with further differentiation for specific antibody types and testing intervals. • The right branch covers cases with no clinically significant antibodies, with a simple repeat testing protocol. # Analysis : • The flowchart provides a clear, stepwise approach for antenatal blood group and antibody screening, emphasizing regular monitoring for women with clinically significant antibodies, especially anti-D, -c, or -K. • It highlights the importance of paternal/fetal genotyping and increased testing frequency for higher-risk cases. • The process ensures that women without significant antibodies receive minimal intervention, while those with antibodies are closely monitored to prevent complications.

This clinical photograph displays a macro-level view of a laboratory specimen on a clear glass microscope slide, demonstrating a positive agglutination reaction. The sample consists of erythrocytes suspended in a liquid medium, which has formed distinct, granular clumps of red cellular material. This macro-clumping is a hallmark of a positive hemagglutination test, where antibodies in the antiserum have cross-linked with antigens on the red blood cell surfaces. The distribution of the red sample is non-uniform, showing a dense, opaque central cluster with irregular, diffuse margins and a lighter peripheral halo where cells are less concentrated. This procedure is commonly used in immunohematology for ABO blood group determination and secretor status analysis via the absorption-inhibition method. The presence of visible clumping in this context signifies a lack of neutralizing antigens in the tested saliva, indicative of a non-secretor phenotype or a positive control result.

<table> <tr> <td>Aggregate Evidence Quality</td> <td>B</td> </tr> <tr> <td>Benefits</td> <td>Early DAT testing identifies newborn infants at risk for immune-mediated hemolytic disease and early hyperbilirubinemia born to mothers who carry anti-erythrocyte antibodies.</td> </tr> <tr> <td>Risk, harm, and cost</td> <td>Early DAT testing could involve an extra blood draw from newborn infants. There is a small risk of false-negative and false-positive DAT test results.</td> </tr> <tr> <td>Benefit-harm assessment</td> <td>Isoimmunization is the most common cause of severe hemolysis, and hyperbilirubinemia can progress rapidly. The alternative to early DAT testing is to wait and only test if jaundice develops, which could miss the opportunity for early intervention in some newborn infants with severe hemolysis. The benefit of knowing the risk for severe hemolysis through early DAT testing likely exceeds the harm of a potential extra blood draw and the risk of a false-negative or false-positive DAT in infants born to mothers with positive or unknown antibody screen results.</td> </tr> <tr> <td>Intentional vagueness</td> <td>None</td> </tr> <tr> <td>Role of patient preferences</td> <td>Minimal to none</td> </tr> <tr> <td>Exclusions</td> <td>None</td> </tr> <tr> <td>Strength</td> <td>Recommendation</td> </tr> <tr> <td>Key references</td> <td>1</td> </tr> </table>

Summary : This flowchart outlines the diagnostic and management pathway for pregnancies affected by maternal alloimmunization to Anti-K, Anti-D, or Anti-c antibodies, focusing on the risk assessment and monitoring for hemolytic disease of the fetus and newborn (HDFN). flowchart: # Nodes : • Anti-K detected (rectangle) • Titrate antibody (rectangle) • Non-invasive pre-natal diagnosis (rectangle) • Test father (rectangle) • K Positive Heterozygous expression (rectangle) • K Positive Homozygous expression (rectangle) • K Negative (rectangle) • cffDNA (rectangle) • K Positive (rectangle) • K Negative (rectangle) • Anti-D detected (rectangle) • Quantify Antibody level 4–15 IU/mL mod risk HDFN >15 IU/mL severe risk HDFN (rectangle) • Non-invasive pre-natal diagnosis (rectangle) • Test father (rectangle) • D Positive Heterozygous expression (rectangle) • D Positive Homozygous expression (rectangle) • D Negative (rectangle) • cffDNA (rectangle) • D Positive (rectangle) • D Negative (rectangle) • Fetus at risk of HDFN (rectangle) • Referral to local Fetal Medicine Specialist for MCA – PSV Doppler (rectangle) • MCA-PSV > 1.5 MoM (rectangle) • Refer to tertiary fetal medicine service with expertise in invasive fetal therapy (IFT) for IUT(s) (rectangle) • MCA-PSV < 1.5 MoM (rectangle) • Serial MCA-PSV studies (rectangle) • Deliver at not later than 37–38 weeks’ gestation, unless other clinical concerns indicate earlier delivery (rectangle) • Cord blood, Hb, Bili, DAT (rectangle) • Anti-c detected (rectangle) • Quantify Antibody level 7.5–20 IU/mL mod risk HDFN >20 IU/mL severe risk HDFN (rectangle) • Non-invasive pre-natal diagnosis (rectangle) • Test father (rectangle) • c Positive Heterozygous expression (rectangle) • c Positive Homozygous expression (rectangle) • c-Negative (rectangle) • cffDNA (rectangle) • c Positive (rectangle) • c Negative (rectangle) • Legend (rectangle) – defines abbreviations used in the chart # Connectors : • Arrows indicate the flow from antibody detection to titration, then to non-invasive diagnosis or paternal testing. • Branches split based on paternal genotype (heterozygous, homozygous, negative). • If the father is negative, the pathway ends (no risk). • If the father is positive (heterozygous or homozygous), cffDNA is used to determine fetal antigen status. • If the fetus is antigen negative, the pathway ends (no risk). • If the fetus is antigen positive, the fetus is at risk of HDFN and referred for further monitoring. • For at-risk fetuses, referral to fetal medicine for MCA-PSV Doppler is indicated. • If MCA-PSV > 1.5 MoM, refer for invasive fetal therapy (IUT). • If MCA-PSV < 1.5 MoM, continue serial monitoring. • Delivery is recommended at 37–38 weeks unless earlier delivery is clinically indicated. # Layout : • The chart is organized into three parallel vertical pathways for Anti-K, Anti-D, and Anti-c, each with similar diagnostic and management steps. • Each pathway splits into non-invasive diagnosis and paternal testing, then converges on fetal risk assessment and management. • The bottom section merges all pathways for final fetal monitoring and delivery planning. • A legend box is present at the bottom left, defining abbreviations. # Analysis : • The flowchart provides a clear, stepwise approach for managing pregnancies at risk of HDFN due to Anti-K, Anti-D, or Anti-c alloimmunization. • The process emphasizes non-invasive testing first, with paternal testing to stratify risk. • Only fetuses at risk (antigen positive) are referred for intensive monitoring and possible intervention. • The use of MCA-PSV Doppler is central for ongoing fetal surveillance, with invasive therapy reserved for those with evidence of fetal anemia. • The chart standardizes care and minimizes unnecessary interventions for low-risk pregnancies.

This physiological waveform diagram displays a simultaneous recording of three cardiac parameters used for assessing cardiovascular hemodynamics. The top trace is an Electrocardiogram (ECG) showing standard QRS complexes representing ventricular depolarization. The middle trace is a Phonocardiogram (PCG) capturing acoustic vibrations of heart sounds, specifically the S1 and S2 sounds. The bottom trace is a Brachial Pulse Volume Waveform (bPVW) illustrating the peripheral arterial pressure pulse. Vertical markers indicate temporal relationships between these signals to calculate systolic time intervals. The 'QS2' interval is marked from the onset of the QRS complex on the ECG to the aortic component of the second heart sound on the PCG, representing the total electromechanical systolic interval. The 'bET' (Brachial Ejection Time) is delineated on the bPVW from the waveform foot to the dicrotic notch. An annotated formula shows the calculation of the Brachial Pre-ejection Period (bPEP) as the difference between QS2 and bET (bPEP = QS2 - bET). This diagram is an educational tool for understanding the non-invasive assessment of cardiac systolic function and arterial stiffness.

Summary : This figure illustrates the left atrial (LA) pressure-volume relationship during the cardiac cycle, showing both time-course traces and a pressure-volume loop, with key phases of atrial function annotated and correlated with the ECG. line plot and loop diagram: # Panel A: LA Pressure and Volume Traces • Top trace: LA Pressure (y-axis, arbitrary units) over time. • Middle trace: LA Volume (y-axis, arbitrary units) over time. • Bottom trace: ECG waveform for temporal reference. • X-axis: Cardiac cycle phases, with systole and diastole labeled; diastole further subdivided into E, D, and A phases. • Five phases are color-coded and numbered: – (1) Atrial filling (red) – (2) Passive emptying (green) – (3) Diastasis (black) – (4) Active emptying (blue) – (5) Atrial relaxation (gray) • Vertical dashed lines demarcate transitions between phases. # Panel B: LA Pressure-Volume Loop • X-axis: LA Volume (arbitrary units). • Y-axis: LA Pressure (arbitrary units). • The loop is traced in a counterclockwise direction, with arrows indicating the sequence. • The same five phases (1–5) are color-coded as in Panel A. • The loop is divided into two segments: A-Loop (phases 1, 3, 4, 5) and V-Loop (phase 2). # Design Encodings : • Distinct colors for each phase (red, green, black, blue, gray). • Arrows on the loop indicate the direction of the cardiac cycle. • ECG trace provides timing reference for the pressure and volume changes. # Analysis : • The LA pressure and volume traces show cyclical changes corresponding to atrial filling, emptying, and relaxation. • The pressure-volume loop visually summarizes the dynamic relationship between LA pressure and volume, with distinct segments for passive and active phases. • The figure highlights the temporal coordination between atrial events and the ECG, emphasizing the mechanical and electrical coupling in the cardiac cycle.

An educational anatomical and physiological diagram illustrating the synchronous collection of multiple cardiovascular biosignals in a canine model. The left side features a lateral-view anatomical illustration of a canine, highlighting the skeletal system, the heart, and major peripheral arteries. Four distinct biosignal waveforms are displayed on the right, with arrows tracing each to its anatomical point of acquisition: 1) LVBP (Left Ventricular Blood Pressure) signal, showing a rhythmic pressure waveform originating from the heart. 2) PPG (Photoplethysmogram) signal, a pulsatile volume waveform traced to the femoral artery. 3) ECG (Electrocardiogram) signal, showing characteristic P-QRS-T complexes with a prominent R-wave, traced to the forelimbs (Lead I configuration). 4) PCG (Phonocardiogram) signal, depicting high-frequency oscillations representing heart sounds, recorded from the cardiac apex. The diagram demonstrates the integration of invasive and non-invasive hemodynamic monitoring, useful for teaching comparative physiology and cardiovascular signal processing.

This diagnostic hemodynamic tracing displays a right atrial (RA) pressure waveform alongside a concurrent electrocardiogram (ECG) lead. The upper section shows a standard ECG rhythm with regular QRS complexes, which serve as a temporal reference for the mechanical events of the cardiac cycle. The lower section depicts the RA pressure tracing, characterized by a significantly elevated mean pressure (approximately 33 mmHg) persisting after pericardiocentesis. The most notable morphologic feature is the presence of sharp, deep 'y' descents, indicated by blue asterisks on the tracing. These descents represent rapid atrial emptying during early ventricular diastole. The combined findings of elevated RA pressure and prominent 'y' descents are visually characteristic of constrictive or effusive-constrictive pericarditis. The tracing illustrates the loss of normal pressure-volume relationships in the right heart due to external restriction, providing a classic example of hemodynamic 'tamponade-like' physiology transitioning toward constriction.

Summary : This figure shows simultaneous pressure recordings from the left ventricle, aortic root, and left atrium over time, illustrating the pressure gradients during the cardiac cycle, including the A-wave and E-wave gradients. line plot: Title & Axes : • No explicit title, but the figure records "simultaneous LV and Ao pressures (the representation of LAP has been added)". • X-axis: "Time" (no units or tick labels shown). • Y-axis: "Pressure (mmHg)" with tick marks at 0 and 100. Data Points : • Red solid line: "Aortic root" pressure. • Blue solid line: "Left ventricle" pressure. • Blue dashed line: "Left atrium" pressure. • Labeled features: "A-wave gradient" (early rise in left atrial pressure), "E-wave gradient" (later rise in left atrial pressure). Design Encodings : • Red solid line for aortic root. • Blue solid line for left ventricle. • Blue dashed line for left atrium. • Labels directly on the plot for anatomical structures and pressure gradients. Distribution & Trends : • Aortic root pressure (red) remains above left ventricular pressure during diastole, then both rise sharply and peak during systole, with the left ventricle slightly higher. • Left atrial pressure (blue dashed) remains low, with small A-wave and E-wave bumps. • The A-wave and E-wave gradients are marked at the points where left atrial pressure rises relative to the left ventricle. Analysis : • The plot demonstrates the normal pressure relationships and timing between the left atrium, left ventricle, and aortic root during the cardiac cycle. • The A-wave and E-wave gradients highlight the phases of atrial contraction and early ventricular filling, respectively. • The left ventricle and aortic root pressures closely track each other during systole, with the aortic root pressure remaining slightly lower during the rapid upstroke and slightly higher during the downstroke. • The left atrial pressure remains much lower than the other two, with characteristic small waves.

This physiological waveform graph displays cardiac simulator signals at a heart rate of 80 bpm, illustrating hemodynamic relationships across the cardiac cycle over a 5-second interval. The upper panel tracks Pressure (mmHg), comparing Left Ventricular Pressure (LVP) and Aortic Pressure (AoP). The LVP waveform shows cyclical rises to approximately 150 mmHg during systole, falling near 0 mmHg in diastole. The AoP oscillates between roughly 105 and 130 mmHg, with distinct high-frequency spikes (dicrotic notches/oscillations) occurring at the moment of mechanical aortic valve closure. The lower panel displays Aortic Root Flow (AoF) in L/min, showing pulsatile flow synchronized with pressure changes. Flow peaks at approximately 20 L/min during the rapid ejection phase and exhibits a brief negative deflection (backflow) to roughly -8 L/min, indicating closure of the aortic valve. These waveforms serve as a diagnostic algorithm illustration for understanding the relationship between chamber pressure, arterial pressure, and forward stroke volume in cardiovascular physiology.

This composite educational graphic details the pathophysiology of myocardial perfusion and coronary hemodynamics. Panel A features a pathophysiology diagram illustrating the extravascular forces and intraluminal pressures affecting the myocardial layers during the cardiac cycle. It compares diastole and systole, highlighting the differences in intramural pressure (PINTRAMURAL), left ventricular lumen pressure (PLUMEN), and pericardial space pressure (PPERICARDIUM). The diagram shows the subendocardial plexus and epicardial artery, emphasizing greater subendocardial compression and reduced vascular volume during systole. Panel B presents a cardiac perfusion quantification map from a patient with aortic stenosis (AS). The map is organized in a grid: rows represent basal, mid, and apical short-axis slices of the left ventricle; columns demonstrate stress perfusion, rest perfusion, and myocardial perfusion reserve (MPR). The color-coded mapping shows regional perfusion distribution, with the MPR column specifically highlighting global limitations in perfusion reserve. This visual is designed for medical education focusing on cardiovascular hemodynamics, coronary microcirculation, and the physiological impact of valvular heart disease on myocardial blood flow.

Summary : This figure presents a pressure–volume loop of the left ventricle, illustrating key cardiac parameters such as end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), end-diastolic pressure (EDP), end-systolic pressure (ESP), arterial elastance (EA), and end-systolic elastance (Ees). The loop visually demonstrates the relationship between ventricular pressure and volume during a cardiac cycle. line plot: # Title & Axes : • Title: "Pressure–volume loop." • X-axis: "Ventricular Volume" (units not specified). – Tick labels: Vo (volume intercept at LV pressure of zero), ESV (end-systolic volume), EDV (end-diastolic volume). • Y-axis: "Ventricular Pressure" (units not specified). – No explicit tick labels shown. # Data & Curve : • Red closed loop traces the pressure–volume relationship during a cardiac cycle. • Horizontal arrow within the loop labeled "SV" (stroke volume) indicates the difference between EDV and ESV. • Vertical segments at EDV and ESV mark transitions between phases. • Dotted lines: – EA (arterial elastance) shown as a dashed line from Vo through ESP/SV. – Ees (end-systolic elastance) shown as a dashed line from Vo through ESP/(ESV-Vo). # Key Parameters & Annotations : • Vo: Volume intercept at LV pressure of zero (leftmost point on x-axis). • ESV: End-systolic volume (right vertical segment). • EDV: End-diastolic volume (far right on x-axis). • SV: Stroke volume (horizontal arrow between ESV and EDV). • EDP: End-diastolic pressure (arrow at bottom right of loop). • ESP: End-systolic pressure (top of loop). • EA: Arterial elastance (dashed line labeled EA (ESP/SV)). • Ees: End-systolic elastance (dashed line labeled Ees = ESP/(ESV-Vo)). # Design Encodings : • Red solid line for the pressure–volume loop. • Blue dashed lines for elastance relationships. • Arrows and labels for key parameters. • No gridlines or axis units specified. # Analysis : • The pressure–volume loop demonstrates the cardiac cycle phases, with the lower right corner representing end-diastole (high volume, low pressure) and the upper left corner representing end-systole (low volume, high pressure). • Stroke volume is visually indicated as the horizontal distance between EDV and ESV. • Elastance lines (EA and Ees) provide graphical representations of arterial and ventricular contractility. • The loop’s shape and annotations allow for assessment of cardiac function and mechanical properties.

Summary : This figure shows a pressure–volume loop for the left ventricle, illustrating how ventricular volume and pressure change during the cardiac cycle, with key phases and valve events annotated. The isovolumetric relaxation and contraction periods are highlighted, and systolic/diastolic blood pressures are marked. pressure–volume loop diagram: # Title & Axes : • No explicit title on the figure, but the legend describes it as a "Pressure–volume loop demonstrating changes in ventricular volume during filling and ejection with corresponding changes in intracavity pressure." • X-axis: "Left ventricular volume (mL)" with tick marks at 0, 20, 40, 60, 80, 100, 120, 140, 160. • Y-axis: "Left ventricular pressure (mmHg)" with tick marks at 0, 20, 40, 60, 80, 100, 120, 140. • Additional axis labels: "Left ventricular end-diastolic pressure" (blue, left), "End-diastolic volume" (blue, bottom right), "Stroke volume" (black, bottom center). # Phases & Events : • Isovolumetric relaxation: vertical line at low volume, pressure drops, labeled. • Diastolic filling: horizontal line at low pressure, volume increases, labeled. • Isovolumetric contraction: vertical line at high volume, pressure rises, labeled. • Ventricular ejection: curved line, volume decreases as pressure peaks and falls, labeled. • Valve events: – Mitral valve opens (bottom left corner, low pressure/volume). – Mitral valve closes (bottom right corner, high volume/low pressure). – Aortic valve opens (top right corner, high volume/high pressure). – Aortic valve closes (top left corner, low volume/high pressure). # Blood Pressure Markers : • Systolic BP: horizontal dashed blue line at ~120 mmHg. • Diastolic BP: horizontal dashed blue line at ~80 mmHg. # Design Encodings : • Black solid lines for the loop. • Blue dashed lines for blood pressure markers. • Blue text for end-diastolic volume/pressure. • Labeled arrows for direction of phases and valve events. # Analysis : • The loop traces the cardiac cycle, starting at low pressure/volume (end-systolic), filling during diastole, rising sharply during isovolumetric contraction, ejecting blood during ventricular ejection, and dropping pressure during isovolumetric relaxation. • Systolic and diastolic blood pressures are marked, showing the pressure range during ejection. • The width of the loop (horizontal distance) represents stroke volume. • The figure clearly distinguishes the four main phases and the timing of valve openings/closings, providing a comprehensive view of ventricular mechanics during a heartbeat.

A multi-panel pathophysiology diagram illustrating the synchronous physiological changes during a standard 28-day human menstrual cycle. The top panel graphs gonadotropin levels, showing a sharp surge in Luteinizing Hormone (LH) and a moderate rise in Follicle-Stimulating Hormone (FSH) at day 14, correlating with the follicular phase, ovulation, and luteal phase stages. The corresponding follicular development shows the maturation of a primary follicle into a Graafian follicle, ovulation, and the formation of the corpus luteum and corpus albicans. The middle panel tracks plasma sex hormone levels, highlighting the mid-cycle peak of Estradiol (E2) and the post-ovulatory rise of Progesterone (P4). The bottom panel depicts endometrial morphology, transitioning from the menstrual phase to the proliferative and secretory phases. A green-shaded layer highlights the glycocalyx development, which thickens and becomes most prominent during the secretory phase under the influence of P4, before thinning during menstruation. The diagram demonstrates the hormonal regulation of the ovary and uterine lining for medical educational purposes.

A pathophysiology diagram illustrating the hypothalamic-pituitary-gonadal (HPG) axis and potential mechanisms for gynecological changes following COVID-19 vaccination or infection. The central axis shows the Hypothalamus releasing GnRH, which stimulates the Anterior Pituitary Gland to release the gonadotropins FSH and LH, acting upon the female reproductive system (uterus and ovaries). A secondary pathway details the 'Multiple COVID-19 vaccine doses stress' response, which is shown to inhibit pulsatile GnRH secretion and promote 'Cortisol upregulation.' This cortisol increase is linked to 'Vaginal microbiota dysregulation' and 'Abnormal Menstrual Bleeding.' Simultaneously, an 'Immune response' from vaccination is depicted affecting 'Ovarian hormones' (Estrogen and Progesterone), also contributing to menstrual irregularities. Finally, the diagram indicates that SARS-CoV-2 infection can lead to 'Angiotensin II dysregulation' via the ACE2 receptor on ovarian tissue, potentially resulting in 'Fertility alterations.' This medical illustration serves to visualize the complex neuroendocrine and immunological interactions impacting reproductive health in the context of viral stress and immune activation.

A comparative medical illustration detailing the mechanisms of action for ovulation induction agents on the hypothalamic-pituitary-ovarian (HPO) axis. Section A depicts the mechanism of Letrozole (LE), showing its inhibitory effect on the aromatase enzyme within the ovary. This blockade prevents the conversion of testosterone and androstenedione to estradiol and estrone, leading to intraovarian androgen accumulation and increased FSH receptor and IGF-1 expression. This process releases the HPO axis from estrogen's negative feedback while maintaining normal central feedback loops. Section B illustrates the mechanism of Clomiphene Citrate (CC), which acts centrally by binding to and blocking estrogenic receptors in the hypothalamus. This inhibits the negative feedback loop of estradiol (marked by red dashed lines and 'X' symbols), thereby stimulating the release of GnRH from the hypothalamus and FSH/LH from the pituitary to promote follicular development. Both diagrams use anatomical icons of the brain and ovary with labeled pathways for GnRH, FSH/LH, and steroid hormones to contrast peripheral enzymatic inhibition versus central receptor antagonism.

This pathophysiology diagram illustrates the hypothalamic-pituitary-gonadal (HPG) axis and various external factors contributing to precocious or rapidly progressive puberty. The central vertical axis displays a downward cascade starting from the hypothalamus, leading to LHRH (GnRH), then the pituitary gland, which secretes LH and FSH. These hormones act on the uterus and ovaries to produce estrogen and progesterone. Surrounding this central axis are several environmental and physiological stressors linked by red arrows. Factors influencing the hypothalamus include SARS-CoV-2 binding to ACE II/NMDA receptors, catecholamines, physical activity changes, mental stress, nutrition, and microbiota alterations. Direct influences on LHRH involve corticosteroids, cortisol, and allopregnanolone. Endocrine-disrupting chemicals are shown targeting the reproductive organs. Positive symbols (+) indicate stimulatory pathways. The diagram serves as an educational tool for endocrinology and pediatrics, highlighting how modern lifestyle factors, infections, and environmental toxins can disrupt normal pubertal timing via neuroendocrine pathways.